For research use only
| Cat No. | ABC-TC0405 |
| Product Type | Human Breast Cancer Cell Lines |
| Cell Type | Epithelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Breast |
| Disease | Breast Cancer |
| Product Code | HS 578T; Hs-578T; HS-578T; Hs_578t; Hs-578-T; HS-578-T; Hs 578.T; HS578T; Hs578T; Hs578t; HS0578T; 578T; HS578; Hs578; Homo sapiens No. 578, tumor cells |
The Hs 578T cell strain was derived from a carcinoma of the breastby A.J. Hackett, et al.
Hs 578T is a human breast cancer cell line derived from a 74-year-old Caucasian female with infiltrating ductal carcinoma. It exhibits a pleomorphic epithelial morphology and forms adherent monolayers. This is a hypotriploid human cell line with a modal chromosome number of 59. QM staining confirmed the loss of the Y chromosome. The rate of polyploidy exceeding the modal number is 33.8%. Hs 578T is non-tumorigenic in immunocompromised mice. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HS 578T; Hs-578T; HS-578T; Hs_578t; Hs-578-T; HS-578-T; Hs 578.T; HS578T; Hs578T; Hs578t; HS0578T; 578T; HS578; Hs578; Homo sapiens No. 578, tumor cells |
| Species | Human |
| Cat.No | ABC-TC0405 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Breast |
| Disease | Breast Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Breast Cancer Cell Lines |
Hs 578T cells are derived from human breast carcinoma and offer a useful model for investigating tumor biology, cancer cell motility, and therapeutic interventions and are widely used in studies on breast cancer stem cell biology and drug resistance. They are valuable for comparing gene expression, drug responses, and epithelial-mesenchymal transition (EMT) with malignant cells.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
